| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +10.1K | 5.6% | $14.81 | +$150K |
| Sells | 4 | -170K | 94.4% | $15.30 | -$2.6M |
| Net | -2 | -160K | -88.8% | -$2.45M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Frazier Life Sciences X, L.P. | 10%+ Owner | $126M | +$128K | +0.1% | Apr 4, 2024 |
| Takeda Pharmaceutical Co Ltd | 10%+ Owner | $104M | Nov 30, 2022 | ||
| Robert Hershberg | President and Chief Executive Officer, Director | $16.8M | -$173K | -1.02% | Feb 8, 2024 |
| David A. Socks | CFO & Chief Business Officer | $11.9M | Apr 28, 2022 | ||
| Aditya Kohli | Director | $11.3M | -$1.67M | -12.9% | May 20, 2024 |
| Astrid Borkowski | Chief Medical Officer | $3.21M | -$706K | -18% | Feb 8, 2024 |
| Shane Maltbie | Chief Financial Officer | $1.32M | -$53.4K | -3.9% | Feb 8, 2024 |
| Susan Silbermann | Director | $651K | Aug 19, 2022 | ||
| Sean McLoughlin | Chief Operating Officer | $21.2K | +$21.2K | Mar 28, 2024 | |
| Jeryl L. Hilleman | Director | Jun 7, 2023 | |||
| Patrick J. Heron | Director, 10%+ Owner | Jun 7, 2023 | |||
| Jaime Sepulveda | Director | Jun 7, 2023 | |||
| Nanette Cocero | Director | Jun 7, 2023 | |||
| Shelley Chu | Director | Aug 19, 2022 | |||
| Julie L. Gerberding | Director | Jun 7, 2023 | |||
| Gary Dubin | Director | Apr 28, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|